At a glance
ClinicalIndex Comparison RecordN/ACompleted· 61 enrolled
Drug / intervention
Conexa Reconstructive Tissue Matrixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center, Single-Arm Study to Assess Clinical Outcomes In Primary Open or Mini-Open Rotator Cuff Repair Using Conexa Graft Reinforcement
In Brief
A clinical study evaluating Conexa Reconstructive Tissue Matrix for Rotator Cuff Tear. Completed, enrolled 61 participants across 6 sites.
Detailed Summary
The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRotator Cuff Tear
CountriesUnited States
CollaboratorsLifeCell
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedDec 2009
Primary CompletionFeb 2014
Study CompletionApr 2014
TodayJul 2026
First PostedDec 3, 2009
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2014
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 16.6 years ago
Interventions
Conexa Reconstructive Tissue Matrixdevice
Conexa will be placed as a soft tissue reinforcement in primary open or mini-open rotator cuff repair procedures